Building Cross-Functional AI Teams in Life Sciences Organizations

Why Cross-Functional AI Teams Are Different in Life Sciences

Life sciences cross-functional AI teams have to do things that AI teams in other industries don’t. Naming the differences helps explain why team designs imported from tech, financial services, or consumer industries reliably underperform in pharma — and why the team design discipline matters as much as it does.

The first difference is regulatory integration. The AI team doesn’t operate in parallel to the regulated functions; it operates through them. SOPs, change control, validation, audit trails — these aren’t downstream concerns the team hands off after the model works. They’re integral to whether the model can ever be deployed. The team has to include regulatory and quality voices from day one, with real authority, not as approvers at the end.

The second is scientific depth. Life sciences AI work depends on biological, clinical, or operational context that takes years to develop. A clinical AI use case without serious clinical input produces models that fit the data without fitting the work. A discovery AI use case without serious computational biology depth produces models that benchmark well but generalize poorly. The team has to include practitioners with deep domain context, integrated with the technical capability, not adjacent to it.

The third is the talent constraint. The combination of skills required — data science, life sciences domain context, regulatory awareness, change management — is rare. The team has to be designed to compose the skills across multiple people rather than expecting them in any single person. The composition design matters because the alternative — hiring unicorns — doesn’t scale.

The fourth is the time horizon. Life sciences AI use cases routinely take 18-36 months from inception to operational deployment, with another 24+ months to capture meaningful value. The team has to be designed for sustained execution, not for sprint cycles. Continuity of personnel matters more than in industries where projects ship in weeks.

The Shape of an Effective Team

Effective cross-functional AI teams in life sciences cluster around a recognizable shape. The shape varies by use case scope — a discovery use case team looks different from a manufacturing use case team — but the structural pattern is consistent.

The team isn’t a project team that disbands at deployment. It’s a sustained capability that owns the use case across its lifecycle. Some roles flex up and down — change and adoption is heavier at deployment, lighter in steady state — but the core continues. Teams designed as project teams that disband produce use cases that drift in the year after deployment because no one owns them at the level required to keep them performant.

The team size varies materially. A Tier 1 use case team may run effectively at 6-10 people; a Tier 3 use case team in clinical operations or manufacturing may require 20-30 people with significant matrix support. Right-sizing matters: under-resourced teams produce slow, fragile work; over-resourced teams produce coordination overhead that slows the work in different ways.

Role Definition and Accountability

The roles within the team have to be defined with sufficient specificity that accountability is unambiguous. Vague accountability is the most common root cause of team underperformance.

Five roles deserve particular attention:

The use case sponsor. A senior business leader with budget authority, organizational standing, and personal stake in the outcome. The sponsor isn’t a steering committee member — they own the use case. Sponsors who treat the role as committee participation produce use cases that drift; sponsors who treat it as ownership produce use cases that deliver.

The product owner. A full-time role that translates between business intent and technical execution. The product owner is the team’s center of gravity — the role that holds the use case together day to day. Strong product owners are scarce and disproportionately determine team performance. Investing in this role pays back across every other team investment.

The lead domain practitioner. A senior clinical, scientific, or operational expert with sustained allocation to the team — typically 50%+ of their time. The role isn’t an advisor; it’s an embedded team member with decision rights on what the use case is supposed to do, what good looks like, and where the model is and isn’t trustworthy. Teams that try to substitute occasional consultation for sustained embedded domain practitioners reliably produce models that miss the work.

The technical lead. The senior technical role accountable for the model and infrastructure. This role coordinates with platform, architecture, and security but bears specific accountability for the use case’s technical performance. The technical lead’s depth and judgment shape what the team can credibly attempt.

The quality and regulatory partner. An embedded QA representative — not a reviewer who shows up at gate reviews. The partner shapes the use case from inception, shares accountability for outcomes, and translates between the regulatory frame and the technical frame. The role’s effectiveness depends substantially on whether the QA function has built or hired the AI-aware practitioners the role requires; many haven’t yet.

Operating Cadence and Decision Rhythm

Team operating cadence matters more than is typically recognized. Cadence shapes how decisions get made, how learning compounds, how risks surface, and how the team’s energy is sustained across the long execution horizons life sciences AI requires.

Several cadence elements consistently appear in well-functioning teams:

• Weekly working sessions for the core team — substantive working meetings, not status updates, where the actual problem-solving happens collaboratively.
• Bi-weekly use case reviews with the sponsor and product owner — checking trajectory against intent, surfacing risks early, making prioritization decisions.
• Monthly governance touchpoints with the cross-functional governance body — keeping QA, regulatory, security, and architecture aligned on the use case’s evolving shape.
• Quarterly executive reviews where the use case sits in the broader portfolio context — checking strategic fit, capital allocation, and cross-use-case learning.
• Annual capability reviews where the team’s own design — composition, roles, processes — gets revisited and refined.

Decision rhythm matters as much as meeting cadence. Teams that batch decisions for weekly meetings move slower than teams with clear in-the-flow decision authority. The product owner’s authority to make most day-to-day decisions, with escalation paths defined for the decisions that require sponsor or governance involvement, is a structural enabler of pace.

Documentation rhythm is the other underrecognized element. Decisions, learnings, and rationale documented in the moment compound across the use case lifecycle and across other use cases. Documentation deferred or treated as overhead erodes — the institutional memory the team accumulates evaporates as personnel turn over, and the next use case repeats lessons the previous use case learned.

Talent Strategy and Sourcing

The talent strategy that supports cross-functional AI teams in life sciences is its own substantial topic. Several principles consistently differentiate organizations that build durable capability from those that struggle.

Composition over unicorns. The skill combination required is too rare to hire as individuals. Build teams that compose the skills across multiple specialists rather than expecting them in any single hire. Hiring strategies built on finding “the AI-savvy clinical scientist with regulatory expertise” produce open requisitions that don’t close; hiring strategies built on composing the skills across collaborating roles produce teams that work.

Internal development alongside external hiring. External hires bring fresh capability and external perspective; internal development brings organizational context and continuity. The organizations building durable AI capability invest in both — not either-or. Internal rotation programs, structured upskilling, and cross-functional development paths create the depth that pure external hiring doesn’t.

Senior anchors at multiple levels. The team needs senior anchors at multiple levels — not just one VP-level leader but senior practitioners in each role cluster. The depth at multiple levels is what differentiates teams that can deliver complex, multi-year use cases from teams that hit ceilings on their first ambitious problem.

Retention as a first-order concern. The skills the team needs are in high demand across industries. Retention has to be designed deliberately — through career paths, compensation, manager quality, and the work itself being meaningful. Organizations that treat retention as someone else’s problem watch their team capability erode under competitor poaching.

Vendor and contractor strategy. Vendors and contractors fill specific, bounded gaps. Used well, they accelerate capability building. Used poorly, they create dependencies that hollow out internal capability over time. The strategy has to be deliberate about which capabilities are sourced internally versus externally, and the boundary has to hold under cost pressure.

The Leadership Behaviors That Matter Most

Beyond structure, role definition, and cadence, several leadership behaviors consistently differentiate teams that deliver from teams that drift. The behaviors are recognizable and learnable.

Sustained presence over heroic interventions. The most effective leaders engage with the team consistently — weekly substantive engagement, not quarterly heroic interventions. The continuous attention shapes decisions in real time; the heroic interventions usually come too late to redirect work that’s already off course.

Public investment of attention. When the leader visibly cares about the team’s work — through time invested, questions asked, public recognition of progress — the team performs differently than when the leader’s attention is intermittent. The public attention also signals to the broader organization that the work matters, which affects the resources and cooperation the team can mobilize.

Comfort with ambiguity at the right level. Effective AI team leaders are comfortable with technical and methodological ambiguity at a level that matches the work. They don’t need every detail resolved before the team moves; they don’t tolerate strategic ambiguity about what the use case is supposed to accomplish. The calibration matters — too tight on technical detail produces micromanagement; too loose on strategic intent produces drift.

Direct conversations about underperformance. When parts of the team aren’t performing, effective leaders address it directly and quickly. Tolerating sustained underperformance signals to the rest of the team that performance doesn’t matter, which is corrosive. The hardest of these conversations are about cross-functional partners whose underperformance is slowing the team — these have to be raised explicitly and resolved at the right level.

Active sponsorship outside the team. The team depends on cross-functional support — data, infrastructure, governance, deployment, change. The leader actively sponsors the team’s work in the broader organization, removing blockers, building relationships, and creating the conditions for cross-functional cooperation. Teams whose leaders don’t do this work spend disproportionate energy navigating cross-functional friction the leader could have removed.

Common Failure Modes

Several failure patterns recur across underperforming teams. Naming them helps leaders recognize the patterns early.

• The technical-only team. Built around data science with domain practitioners as advisors and quality and regulatory as gatekeepers. Produces work that’s technically sound but doesn’t fit the work it’s supposed to support.
• The committee team. Distributed accountability across so many functions that no role has clear ownership. Decisions move slowly. The team performs at the speed of the slowest cross-functional approval.
• The seconded team. Members are nominally on the team but report up through their home functions, with conflicting priorities and divided attention. The team never coheres into a real unit; performance is the sum of fractions.
• The talent-light team. Built without senior anchors at the levels the work requires. Hits ceilings on its first ambitious use case and never scales beyond foundational work.
• The handoff team. Designed as a project team that delivers a model and disbands. Use cases drift after deployment because no continuing team owns them at the level required.
• The cadence-light team. Meets infrequently, makes decisions reactively, documents rarely. Produces work that’s both slower and lower-quality than its skills would predict.
• The sponsor-distant team. Sponsor engages quarterly at most, doesn’t shape priorities, doesn’t remove blockers. Team operates without the strategic and political support the work requires.

Each failure mode is recoverable if caught early. All of them compound if ignored. The discipline of reviewing the team’s own design periodically — separately from reviewing the use case work — is what catches the failure modes before they become structural.

Scaling the Team Model

Single-team success doesn’t automatically scale to multi-team capability. Several patterns differentiate organizations that scale the team model successfully from those that don’t.

Shared capability infrastructure. Platform, governance, talent development, and methodology are shared across teams rather than reinvented per team. The shared infrastructure creates leverage and consistency. The teams focus on their use cases rather than rebuilding common foundations.

Methodology and pattern libraries. Common patterns — for use case definition, validation, deployment, change management — are codified and shared. New teams accelerate by drawing on accumulated patterns rather than starting from scratch.

Cross-team learning forums. Periodic forums where teams share learnings, surface common challenges, and develop solutions collectively. The forums build the cross-team community of practice that single teams alone can’t generate.

Talent rotation. Practitioners rotate across teams over time, carrying methodology, learning, and relationships. Rotation also creates career paths that retain talent across multi-year horizons.

Portfolio-level governance. The portfolio of teams is governed at a level above any single team, with explicit attention to portfolio composition, capability investment, and performance benchmarks. Without portfolio governance, individual teams optimize locally in ways that produce sub-optimal portfolios.

The scaling work is harder than the initial team-building work. Many organizations build one or two strong teams and then plateau because the scaling discipline isn’t in place. The organizations that build durable enterprise AI capability are the ones that invest in scaling infrastructure as deliberately as they invest in initial teams — and that recognize the scaling challenge as distinct from the team-building challenge it builds upon.

Cross-functional AI teams in life sciences are, in the end, the operational unit that determines whether AI strategy translates into outcomes. Strong strategy with weak teams produces frustration; adequate strategy with strong teams produces results. The team design discipline is one of the highest-leverage investments a senior AI leader can make — and one of the most consistently underestimated.

The investment that pays back over years

One final perspective worth holding as senior leaders make team-design decisions: the investment compounds over years, not quarters. A well-designed team that delivers its first use case in 18-24 months becomes the foundation for the second use case, which delivers faster. By the third or fourth use case, the team’s accumulated methodology, infrastructure, and judgment let it operate at a velocity and quality the first use case team couldn’t have approached. The cumulative advantage is the difference between organizations whose AI capability becomes a strategic asset and organizations whose AI capability remains a collection of individually managed projects.

The corollary is that the early team-design decisions matter disproportionately. Teams designed well from the start build the foundation that compounds; teams designed poorly accumulate technical debt, cultural debt, and governance debt that the organization either pays to remediate later or quietly absorbs as performance ceiling. The hour spent on thoughtful team design at the start typically saves multiple quarters of remediation later — and the leaders who recognize this consistently invest the design time deliberately rather than treating team design as something to be improvised under deadline pressure.

References